1. Home
  2. NVO vs WFC Comparison

NVO vs WFC Comparison

Compare NVO & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$38.55

Market Cap

269.6B

Sector

Health Care

ML Signal

HOLD

Logo Wells Fargo & Company

WFC

Wells Fargo & Company

HOLD

Current Price

$80.26

Market Cap

290.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVO
WFC
Founded
1923
1852
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
269.6B
290.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NVO
WFC
Price
$38.55
$80.26
Analyst Decision
Hold
Buy
Analyst Count
11
16
Target Price
$51.00
$97.37
AVG Volume (30 Days)
21.6M
14.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.15%
2.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.46
Revenue Next Year
$4.39
$4.55
P/E Ratio
$13.60
$14.15
Revenue Growth
N/A
N/A
52 Week Low
$35.85
$58.42
52 Week High
$82.23
$97.76

Technical Indicators

Market Signals
Indicator
NVO
WFC
Relative Strength Index (RSI) 31.52 34.81
Support Level N/A $77.38
Resistance Level $50.30 $85.22
Average True Range (ATR) 0.89 2.74
MACD -0.21 -0.51
Stochastic Oscillator 19.46 21.64

Price Performance

Historical Comparison
NVO
WFC

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About WFC Wells Fargo & Company

Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.

Share on Social Networks: